Removal of the EvolutionĀ® Esophageal Stent - Fully Covered (NCT01900691) | Clinical Trial Compass
CompletedNot Applicable
Removal of the EvolutionĀ® Esophageal Stent - Fully Covered
United States130 participantsStarted 2013-09
Plain-language summary
The CLARITY study is a clinical trial approved by US FDA to study the removal of the EvolutionĀ® Esophageal Stent-Fully Covered in malignant and benign indications.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient is diagnosed with benign or malignant stricture, fistula, perforation, or leak
* Physician plans to remove the stent within the duration of study follow-up
Exclusion Criteria:
* Patient is \< 18 years of age
* Patient is unable or unwilling to provide written informed consent or comply with follow-up schedule
* Patient is pregnant, lactating, or planning on being pregnant within the next 6 months
* Patient is simultaneously participating in another investigational drug or device study
* Patient that is contraindicated to upper GI endoscopy and/or any procedure to be performed in conjunction with esophageal stent placement
* Patient has a known hypersensitivity or contraindication to study products that, in the opinion of the investigator, cannot be adequately pre-medicated
What they're measuring
1
Number of Patients With Successful Removal of Study Stent